Form NT 20-F - Notification of inability to timely file Form 20-F:
SEC Accession No. 0001193125-25-260712
Filing Date
2025-10-31
Accepted
2025-10-31 16:01:16
Documents
1
Period of Report
2025-06-30
Effectiveness Date
2025-10-31

Document Format Files

Seq Description Document Type Size
1 NT 20-F d42131dnt20f.htm NT 20-F 20307
  Complete submission text file 0001193125-25-260712.txt   21651
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: NT 20-F | Act: 34 | File No.: 000-29962 | Film No.: 251440407
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)